Egenskap
Dizziness
Klinisk navn: Vertigo
An abnormal sensation of spinning while the body is actually stationary.
Sammendrag
- Også kalt
- Dizzy spell
- Kroppssystem
- Abnormality of the ear
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Dizziness, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test140 gener knyttet til Dizziness
Endringer i disse genene forårsaker sjeldne tilstander der Dizziness forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ATP6V1B1ATPase H+ transporting V1 subunit B1 | Alltid | I 1 tilstand |
| EMDemerin | Alltid | I 1 tilstand |
| FDXRferredoxin reductase | Alltid | I 1 tilstand |
| GCGRglucagon receptor | Alltid | I 1 tilstand |
| LAMB1laminin subunit beta 1 | Alltid | I 1 tilstand |
| MAU2MAU2 sister chromatid cohesion factor | Alltid | I 1 tilstand |
| NOTCH3notch receptor 3 | Alltid | I 1 tilstand |
| RFC4replication factor C subunit 4 | Alltid | I 1 tilstand |
| RRP12ribosomal RNA processing 12 homolog | Alltid | I 2 tilstander |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Alltid | I 2 tilstander |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Alltid | I 1 tilstand |
| ADA2adenosine deaminase 2 | Svært ofte (80–99 %) | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Svært ofte (80–99 %) | I 6 tilstander |
| EPORerythropoietin receptor | Svært ofte (80–99 %) | I 2 tilstander |
| JAK2Janus kinase 2 | Svært ofte (80–99 %) | I 4 tilstander |
| JUPjunction plakoglobin | Svært ofte (80–99 %) | I 1 tilstand |
| NAGAalpha-N-acetylgalactosaminidase | Svært ofte (80–99 %) | I 3 tilstander |
| SLC1A3solute carrier family 1 member 3 | Svært ofte (80–99 %) | I 2 tilstander |
| ABCC9ATP binding cassette subfamily C member 9 | Ofte (30–79 %) | I 1 tilstand |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Ofte (30–79 %) | I 2 tilstander |
| BCORBCL6 corepressor | Ofte (30–79 %) | I 1 tilstand |
| CACNB4calcium voltage-gated channel auxiliary subunit beta 4 | Ofte (30–79 %) | I 2 tilstander |
| CALRcalreticulin | Ofte (30–79 %) | I 1 tilstand |
| CCND1cyclin D1 | Ofte (30–79 %) | I 2 tilstander |
| CMPK2cytidine/uridine monophosphate kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| DKK1dickkopf Wnt signaling pathway inhibitor 1 | Ofte (30–79 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Ofte (30–79 %) | I 1 tilstand |
| GATA2GATA binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 1 tilstand |
| GATA5GATA binding protein 5 | Ofte (30–79 %) | I 1 tilstand |
| GATA6GATA binding protein 6 | Ofte (30–79 %) | I 1 tilstand |
| GJA5gap junction protein alpha 5 | Ofte (30–79 %) | I 1 tilstand |
| GYG1glycogenin 1 | Ofte (30–79 %) | I 1 tilstand |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| JAM2junctional adhesion molecule 2 | Ofte (30–79 %) | I 1 tilstand |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Ofte (30–79 %) | I 2 tilstander |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Ofte (30–79 %) | I 1 tilstand |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Ofte (30–79 %) | I 1 tilstand |
Vis 100 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Ofte (30–79 %) | I 1 tilstand |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Ofte (30–79 %) | I 1 tilstand |
| LRP4LDL receptor related protein 4 | Ofte (30–79 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Ofte (30–79 %) | I 2 tilstander |
| MYD88MYD88 innate immune signal transduction adaptor | Ofte (30–79 %) | I 1 tilstand |
| MYL4myosin light chain 4 | Ofte (30–79 %) | I 1 tilstand |
| MYORGmyogenesis regulating glycosidase | Ofte (30–79 %) | I 1 tilstand |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NKX2-5NK2 homeobox 5 | Ofte (30–79 %) | I 2 tilstander |
| NKX2-6NK2 homeobox 6 | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| NPPAnatriuretic peptide A | Ofte (30–79 %) | I 2 tilstander |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Ofte (30–79 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NUP155nucleoporin 155 | Ofte (30–79 %) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Ofte (30–79 %) | I 2 tilstander |
| PDGFRBplatelet derived growth factor receptor beta | Ofte (30–79 %) | I 1 tilstand |
| PITX2paired like homeodomain 2 | Ofte (30–79 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| PRRT2proline rich transmembrane protein 2 | Ofte (30–79 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| RYR1ryanodine receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Ofte (30–79 %) | I 2 tilstander |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Ofte (30–79 %) | I 2 tilstander |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Ofte (30–79 %) | I 1 tilstand |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Ofte (30–79 %) | I 1 tilstand |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Ofte (30–79 %) | I 3 tilstander |
| SH2B3SH2B adaptor protein 3 | Ofte (30–79 %) | I 2 tilstander |
| SLC20A2solute carrier family 20 member 2 | Ofte (30–79 %) | I 1 tilstand |
| SRPK3SRSF protein kinase 3 | Ofte (30–79 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Ofte (30–79 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 1 tilstand |
| SUFUSUFU negative regulator of hedgehog signaling | Ofte (30–79 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 1 tilstand |
| TP53tumor protein p53 | Ofte (30–79 %) | I 1 tilstand |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Ofte (30–79 %) | I 1 tilstand |
| TTNtitin | Ofte (30–79 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Ofte (30–79 %) | I 2 tilstander |
| VSX1visual system homeobox 1 | Ofte (30–79 %) | I 1 tilstand |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Ofte (30–79 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Noen ganger (5–29 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Noen ganger (5–29 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CDH23cadherin related 23 | Noen ganger (5–29 %) | I 2 tilstander |
| CHD2chromodomain helicase DNA binding protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CNNM2cyclin and CBS domain divalent metal cation transport mediator 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CUX2cut like homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| DBHdopamine beta-hydroxylase | Noen ganger (5–29 %) | I 1 tilstand |
| DNM1dynamin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| FASFas cell surface death receptor | Noen ganger (5–29 %) | I 2 tilstander |
| FGF14fibroblast growth factor 14 | Noen ganger (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| FOXI1forkhead box I1 | Noen ganger (5–29 %) | I 1 tilstand |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Noen ganger (5–29 %) | I 1 tilstand |
| GCDHglutaryl-CoA dehydrogenase | Noen ganger (5–29 %) | I 1 tilstand |
| GLAgalactosidase alpha | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Noen ganger (5–29 %) | I 3 tilstander |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Noen ganger (5–29 %) | I 2 tilstander |
| IFNGR1interferon gamma receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IL10interleukin 10 | Noen ganger (5–29 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Noen ganger (5–29 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IL12Binterleukin 12B | Noen ganger (5–29 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Noen ganger (5–29 %) | I 1 tilstand |
| KCNJ10potassium inwardly rectifying channel subfamily J member 10 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Noen ganger (5–29 %) | I 1 tilstand |
| MAPK10mitogen-activated protein kinase 10 | Noen ganger (5–29 %) | I 1 tilstand |
| MED12mediator complex subunit 12 | Noen ganger (5–29 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Noen ganger (5–29 %) | I 1 tilstand |
| MEN1menin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Noen ganger (5–29 %) | I 1 tilstand |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Noen ganger (5–29 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Noen ganger (5–29 %) | I 2 tilstander |
| SLC26A4solute carrier family 26 member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Noen ganger (5–29 %) | I 1 tilstand |
| THPOthrombopoietin | Noen ganger (5–29 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Noen ganger (5–29 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Sjelden (1–4%) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Sjelden (1–4%) | I 1 tilstand |
| CTNNB1catenin beta 1 | Sjelden (1–4%) | I 1 tilstand |
| NOP56NOP56 ribonucleoprotein | Sjelden (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjelden (1–4%) | I 2 tilstander |
| CALM1calmodulin 1 | Ikke registrert | I 1 tilstand |
| COCHcochlin | Ikke registrert | I 1 tilstand |
| MVKmevalonate kinase | Ikke registrert | I 1 tilstand |
| MYL2myosin light chain 2 | Ikke registrert | I 1 tilstand |
| MYO7Amyosin VIIA | Ikke registrert | I 2 tilstander |
| TPK1thiamin pyrophosphokinase 1 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker